This inventor holds 4 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1995-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (1995)
- Toyonaka, JP (1995 - 2003)
Company Filing History:
Years Active: 1995-2003
Title: Hidetoshi Horibe: Innovator in Antimycotic Drug Composition
Introduction
Hidetoshi Horibe is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug compositions. With a total of 4 patents to his name, Horibe's work has had a meaningful impact on medical treatments.
Latest Patents
One of Horibe's latest patents is focused on an antimycotic drug composition. This innovation involves sustained release preparations that utilize a matrix produced by dispersing a pharmaceutically active ingredient into a solid matrix at ambient temperature. The matrix is comprised of a fatty acid ester of a polyglycerol, which provides stable release-controlling ability. This preparation can be processed into various forms, including fine granules, granules, capsules, and tablets. It aims to reduce the administration frequency of the active ingredient while minimizing side effects.
Career Highlights
Hidetoshi Horibe is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on innovative drug formulations that enhance patient care and treatment efficacy.
Collaborations
Throughout his career, Horibe has collaborated with esteemed colleagues such as Minoru Yoshioka and Yohko Akiyama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Hidetoshi Horibe's contributions to the field of pharmaceuticals, particularly in antimycotic drug compositions, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the industry and enhance patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
